← Browse by Condition
Medical Condition
solid tumor unspecified adult
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 1, Phase 2
ClinicalMetric tracks all active clinical trials for solid tumor unspecified adult sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1 3
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
NCT05695638
Recruiting
Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment
Enrollment
3,000 pts
Location
Denmark
Sponsor
Morten Ladekarl
NCT06883539 Phase 1
Recruiting
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Enrollment
24 pts
Location
Taiwan
Sponsor
LaunXP Biomedical Co., Ltd.
NCT04443088 Phase 1
Recruiting
An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors
Enrollment
78 pts
Location
United States
Sponsor
Shenzhen Ionova Life Sciences ...
NCT06911333 Phase 1, Phase 2
Recruiting
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
Enrollment
36 pts
Location
South Korea
Sponsor
Avelos Therapeutics Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology